Pituitary Tumours: Problems and Questions

  • G. M. Teasdale
  • A. M. McNicol
  • J. A. Thomson
  • D. L. Davies
Conference paper
Part of the Acta Neurochirurgica book series (NEUROCHIRURGICA, volume 47)


There have been many advances in the understanding and treatment of pituitary tumours in the last two decades. The basic scientific and clinical literature is now extensive and excellent reviews can be found in textbooks and journals. Despite this, important problems remain unresolved. This paper presents a personal viewpoint of these problems and seeks to identify some of the questions that neurosurgical research workers might aim to answer. These concern the methods of diagnosis of pituitary tumours and the assessment of their effects, their natural history, the indications for treatment and the advantages of different methods of management, how the results of treatment are assessed and how they may be improved.


Pituitary Adenoma Pituitary Tumour Serum Prolactin Normal Pituitary Gland Pituitary Fossa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams EF, Mashiter K (1985) Role of cell and explant culture in the diagnosis and characterization of human pituitary tumours. Neurosurg Review 8: 135–140CrossRefGoogle Scholar
  2. Balagura S, Derome P, Guiot G (1981) Acromegaly analysis of 132 cases treated surgically. Microsurgery 8: 413–416Google Scholar
  3. Breidahl H, Topliss JD, Pike JW (1983) Failure of bromocriptine to maintain reduction in size of a macroprolactinoma. Br Med J 287: 451–452CrossRefGoogle Scholar
  4. Brown SB, Murphy Irwin K, Enzmann DR (1983) CT characteristics of the normal pituitary gland. Neuroradiology 24: 259–262PubMedCrossRefGoogle Scholar
  5. Burch W (1983) A survey of results with transsphenoidal surgery in Cushing’s disease. N Engl J Med 308: 103–104PubMedCrossRefGoogle Scholar
  6. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K (1981) Microadenomas of the pituitary and abnormal sella tomograms in an unselected autopsy series. New Engl J Med 304: 156–158PubMedCrossRefGoogle Scholar
  7. Davies DL, Beastall GH, McConnell J, Fraser R, McCruden D, Teasdale GH (1985) Body composition, blood pressure and the renin angiotensin system in acromegaly before and after treatment. J Hypertension 3: S 413 – S415Google Scholar
  8. Davis PL, Hoffman JC, Spencer T, Tindall GT, Braun IF (1987) MR imaging of pituitary adenomas: CT, clinical and surgical correlations. AJNR 8: 107–110Google Scholar
  9. Elias KA, Weiner RJ (1984) Direct arterial vascularization of estrogen induced prolactin-secreting anterior pituitary tumours. Proc Natl Acad Sci USA 81: 4549–4553PubMedCrossRefGoogle Scholar
  10. Erroi A, Bassetti M, Spada A, Giannattasio G (1986) Microvasculature of human micro-and macroprolactiomas. Neuroendocrinology 43: 159–165PubMedCrossRefGoogle Scholar
  11. Fahlbusch R, Buchfelder M, Muller OA (1986) Transsphenoidal surgery for Cushing’s syndrome. J Roy Soc Med 79: 202–209Google Scholar
  12. Fahlbusch R, Buchfelder M, Muller OA Schell V (1987) Short term pre-treatment of macroprolactinomas by dopamine agonists. J Neurosurg 67: 807–815PubMedCrossRefGoogle Scholar
  13. Findlay G, McFadzean RM, Teasdale GM (1983) Recovery of vision following treatment of pituitary tumours, application of a new system of assessment to patients treated by transsphenoidal operation. Acta Neurochir 68: 175–186CrossRefGoogle Scholar
  14. Hardy J, Vezina JL (1976) Transsphenoidal neurosurgery of intra-cranial neoplasms. In: Thompson RA, Green JR (eds) Advances in neurology. Raven Press, New York, pp 761–774Google Scholar
  15. Hardy J, Vezina JL (1982) Cushing’s disease 50 years later on. Can J Neurol Sci 9: 375–380PubMedGoogle Scholar
  16. Hardy J, Vezina JL (1969) Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 10: 185–217Google Scholar
  17. Howlett TA, Rees LH (1985) Is it possible to diagnose pituitary-dependent Cushing’s disease? Ann Clin Biochem 22: 550–558PubMedGoogle Scholar
  18. Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW (1980) Decreased bone density in hyperprolactinaemic women. New Engl J Med 303: 1511–1514PubMedCrossRefGoogle Scholar
  19. Kovacs K, Horvath E (1986) Tumours of the pituitary gland. Armed Forces Institute Pathology Publications, Washington D.C., 269Google Scholar
  20. Kucharcyk W, Davis DO, Kelly WM, Sze G, Normal D, Newton TH (1986) Pituitary adenomas: high resolution MR imaging at 1.5T. Radiology 161: 761–765Google Scholar
  21. Lancet editorial (1987) Hyperprolactinaemia: when is a prolactinoma not a prolactinoma? Lancet ii: 1002–1004Google Scholar
  22. Landolt AH (1984) Secreting pituitary adenomas: morphological and biological aspects in pituitary hyperfunction. In: Camanni F, Miller, E (eds) Serino symposia publications vol 10. Raven press, New York, pp 135–155Google Scholar
  23. Landolt AM, Hertz PV (1986) Alpha-Subunit-producing pituitary adenomas: immunocytochemical and ultrastructural studies. Virchows Arch (Pathol Anat) 409: 417–431CrossRefGoogle Scholar
  24. Landolt AM, Hertz PV, Valavanis A, Girard J, Eberle AN (1986) Corticotrophin releasing factor test used with bilateral simultaneous inferior petrosal sinus blood-sampling for the diagnosis of pituitary dependent Cushing’s disease. Clin Endocrinol 14: 133–143Google Scholar
  25. Laws ER, Fode NL, Redmond MJ (1985) Transsphenoidal surgery following unsuccessful prior therapy. J Neurosurg 63: 823–829PubMedCrossRefGoogle Scholar
  26. Lawton NF (1987) Prolactinomas: medical or surgical treatment? Quart J Med 64: 557–564PubMedGoogle Scholar
  27. Lees P, Pickard JD (1987) Hyperprolactinaemia intrasellar pituitary tissue pressure and the pituitary stalk compression syndrome. J Neurosurg 67: 192–196PubMedCrossRefGoogle Scholar
  28. Liuzzi A, Dallabonzana D, Opizzi G et al. (1985) Low doses of dopamine agonists in the long-term treatment of macroprolactinoma. New Engl J Med 313: 656–659PubMedCrossRefGoogle Scholar
  29. Macpherson P, Teasdale E, Hadley DM, Teasdale G (1987) Invasive v non-invasive assessment of the carotid arteries prior to transsphenoidal surgery. Neuroradiology 29: 457–461PubMedCrossRefGoogle Scholar
  30. McLellan A, Connell JMC, Beastall Jet al. (1988) Growth hormone, body composition and somatomedin C after treatment of acromegaly. Quart J Med 69: 997–1008PubMedGoogle Scholar
  31. Molitch ME, Elton RL, Blackwell RE et al. (1985) Bromocriptine as a primary therapy for prolactin-secreting macroadenomasresults of a prospective multi-center study. J Clin Endocrinol Metab 60: 698–705PubMedCrossRefGoogle Scholar
  32. Montini M, Pagani G, Goanola D et al. (1986) Long lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas of a long acting injectable form of bromocriptine. J Clin Endocrinol Metab 63: 266–268PubMedCrossRefGoogle Scholar
  33. Oldfield EH, Chrousos GP, Schultz HM, Schaaf M, McKeevert PE, Krudy AG, Cutter GB, Loriauz DL, Doppman FL (1985) Preoperative lateralization of ACTH-secreting microadenoma by bilateral and simultaneous inferior petrosal sinus sampling. New Engl J Med 312: 100–103PubMedCrossRefGoogle Scholar
  34. Pontirolli AE, Falsetti L (1984) Development of pituitary adenoma in women with hyperprolactinaemia clinical, endocrine and radiological characteristic. Br Med J 288: 515–518CrossRefGoogle Scholar
  35. Powell DF, Baker HZ, Laws ER (1974) The primary angiographie findings in pituitary adenomas. Radiography 110: 589–595Google Scholar
  36. Rappolo HM, Latchaw RE (1983) Normal pituitary gland 1) Macroscopic anatomy—CT correlation. AJNR 4: 927–936Google Scholar
  37. Schaison G, Louzinet D, Moatti N, Pertuiset B (1983) Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery. Clin Endocrinol 14: 133–143Google Scholar
  38. Scotti G, Scialfa G, Pieralli S, Chiodini PS, Spelta B, Dallabonzana D (1982) Macroprolactinomas: CT evaluation of reduction of tumour size after medical treatment. Neuroradiology 23: 123126Google Scholar
  39. Serri O, Rasio E, Beauregard H, Hardy J, Somma M (1983) Recurrence of hyperprolactinaemia after selective transsphenoidal adenomectomy in women with prolactinoma. New Engl J Med 209: 280–283CrossRefGoogle Scholar
  40. Stefanko SZ, Lamberts SWJ, Osteram R (1983) Relationship between cytological picture and hormone secretion by human pituitary adenomas in cell culture. Arch Neuropathol (Berl) OL 153–156Google Scholar
  41. Swartz JD, Russell K, Basile BA, O’Donnel PC, Popky GL (1983) High resolution computed tomographic appearance of the intrasellar contents in women of child-bearing age. Radiology 147: 115–117PubMedGoogle Scholar
  42. Teasdale G (1983) Surgical management of pituitary adenoma. Clin Endocrinol Metab 12: 789–823PubMedCrossRefGoogle Scholar
  43. Teasdale E, Teasdale GM, Mohsen F, Macphersen P (1986) High resolution computed tomography in pituitary microadenomas: is seeing receiving? Clinical radiology 37: 227–232PubMedCrossRefGoogle Scholar
  44. Thomson JA, Teasdale GM, Gordon D, McCruden D, Davies DL (1985) Treatment of presumed prolactinoma by transsphenoidal operation; early and late results. Br Med J 29: 1550–1553CrossRefGoogle Scholar
  45. Weiss MH, Teal J, Gott P (1983) Natural history of microprolactinoma, six year follow up. Neurosurgery 12: 180–183PubMedCrossRefGoogle Scholar
  46. Wrighton P (1978) Conservative removal of small pituitary tumours: is it justified by the pathological findings? J Neurol Neurosurg Psychiat 41: 183–299Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • G. M. Teasdale
    • 1
  • A. M. McNicol
    • 2
  • J. A. Thomson
    • 3
  • D. L. Davies
    • 4
  1. 1.University Department of Neurosurgery, Institute of Neurological SciencesSouthern General HospitalGlasgowUK
  2. 2.University Department of PathologyRoyal InfirmaryGlasgowUK
  3. 3.University Department of MedicineRoyal InfirmaryGlasgowUK
  4. 4.Department of MedicineWestern InfirmaryGlasgowUK

Personalised recommendations